Regulation of insulin sensitivity, insulin production, and pancreatic β cell survival by angiotensin-(1-7) in a rat model of streptozotocin-induced diabetes mellitus

Peptides

Volumn 64, Issue , 2015, Pages 49-54

  He, Junhua ^a   Yang, Zhiming ^a   Yang, Huiyu ^a   Wang, Li ^a   Wu, Huilu ^a   Fan, Yunjuan ^a   Wang, Wei ^a   Fan, Xin ^a   Li, Xing ^a  

^a SHANXI MEDICAL UNIVERSITY   (China)

Author keywords

Angiotensin (1 7); Cell apoptosis; Islet function; Oxidative stress; Type 2 diabetes mellitus

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 5; ANGIOTENSIN 6; ANGIOTENSIN 7; ANGIOTENSIN I; ANGIOTENSIN II; ANGIOTENSIN II [3-8]; ANGIOTENSIN III; CASPASE 3; CASPASE 8; CASPASE 9; GLUCOSE; INDUCIBLE NITRIC OXIDE SYNTHASE; INSULIN; UNCLASSIFIED DRUG; ANGIOTENSIN I (1-7); ANTIDIABETIC AGENT; APOPTOSIS REGULATORY PROTEIN; PEPTIDE FRAGMENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDIABETIC ACTIVITY; ARTICLE; CELL SURVIVAL; CHROMATIN; CONTROLLED STUDY; DIET RESTRICTION; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; IMMUNOHISTOCHEMISTRY; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; INSULIN SYNTHESIS; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATIVE STRESS; PANCREAS ISLET; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; RAT; REAL TIME POLYMERASE CHAIN REACTION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; WESTERN BLOTTING; ANIMAL; DIABETES MELLITUS, EXPERIMENTAL; DISEASE MODEL; DRUG EFFECTS; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; SECRETION (PROCESS); WISTAR RAT;

RATTUS; RATTUS NORVEGICUS;

ANGIOTENSIN I; ANIMALS; APOPTOSIS REGULATORY PROTEINS; CELL SURVIVAL; DIABETES MELLITUS, EXPERIMENTAL; DISEASE MODELS, ANIMAL; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN RESISTANCE; INSULIN-SECRETING CELLS; MALE; PEPTIDE FRAGMENTS; RATS; RATS, WISTAR;

EID: 84921501973     PISSN: 01969781     EISSN: 18735169     Source Type: Journal    
DOI: 10.1016/j.peptides.2014.12.012     Document Type: Article

References (35)

1. A. Akbarzadeh, D. Norouzian, M.R. Mehrabi, S. Jamshidi, A. Farhangi, and A.A. Verdi Induction of diabetes by Streptozotocin in rats Indian J Clin Biochem 22 2007 60 64
2. S.M. Bindom, C.P. Hans, H. Xia, A.H. Boulares, and E. Lazartigues Angiotensin I-converting enzyme type 2 (ACE2) gene therapy improves glycemic control in diabetic mice Diabetes 59 2010 2540 2548
3. K.A. Broniowska, B.J. Oleson, and J.A. Corbett β-Cell responses to nitric oxide Vitam Horm 95 2014 299 322
4. X. Cao, F.Y. Yang, Z. Xin, R.R. Xie, and J.K. Yang The ACE2/Ang-(1-7)/Mas axis can inhibit hepatic insulin resistance Mol Cell Endocrinol 393 2014 30 38
5. K.H. Chhabra, H. Xia, K.B. Pedersen, R.C. Speth, and E. Lazartigues Pancreatic angiotensin-converting enzyme 2 improves glycemia in angiotensin II-infused mice Am J Physiol Endocrinol Metab 304 2013 E874 E884
6. K.Y. Chu, T. Lau, P.O. Carlsson, and P.S. Leung Angiotensin II type 1 receptor blockade improves beta-cell function and glucose tolerance in a mouse model of type 2 diabetes Diabetes 55 2006 367 374
7. A. Gross, X.M. Yin, K. Wang, M.C. Wei, J. Jockel, and C. Milliman Caspase cleaved BID targets mitochondria and is required for cytochrome c release, while BCL-XL prevents this release but not tumor necrosis factor-R1/Fas death J Biol Chem 274 1999 1156 1163
8. S.J. Koopmans, Z. Mroz, R. Dekker, H. Corbijn, M. Ackermans, and H. Sauerwein Association of insulin resistance with hyperglycemia in streptozotocin-diabetic pigs: effects of metformin at isoenergetic feeding in a type 2-like diabetic pig model Metabolism 55 2006 960 971
9. Y. Kurohane Kaneko, and T. Ishikawa Dual role of nitric oxide in pancreatic β-cells J Pharmacol Sci 123 2013 295 300
10. -ΔΔCt method Methods 25 2001 402 408
11. C.L. Lu, Y. Wang, L. Yuan, Y. Li, and X.Y. Li The angiotensin-converting enzyme 2/angiotensin (1-7)/Mas axis protects the function of pancreatic β cells by improving the function of islet microvascular endothelial cells Int J Mol Med 2014 10.3892/ijmm.2014.1917 [Epub ahead of print]
12. J. Lu, T. Jiang, L. Wu, L. Gao, Y. Wang, and F. Zhou The expression of angiotensin-converting enzyme 2-angiotensin-(1-7)-Mas receptor axis are upregulated after acute cerebral ischemic stroke in rats Neuropeptides 47 2013 289 295
13. I. Martín-Timón, C. Sevillano-Collantes, A. Segura-Galindo, and F.J. Del Cañizo-Gómez Type 2 diabetes and cardiovascular disease: have all risk factors the same strength? World J Diabetes 5 2014 444 470
14. D.R. Matthews, J.P. Hosker, A.S. Rudenski, B.A. Naylor, D.F. Treacher, and R.C. Turner Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man Diabetologia 28 1985 412 419
15. L.A. Meusel, N. Kansal, E. Tchistiakova, W. Yuen, B.J. MacIntosh, and C.E. Greenwood A systematic review of type 2 diabetes mellitus and hypertension in imaging studies of cognitive aging: time to establish new norms Front Aging Neurosci 6 2014 148
16. T.M. Murça, P.L. Moraes, C.A. Capuruço, S.H. Santos, M.B. Melo, and R.A. Santos Oral administration of an angiotensin-converting enzyme 2 activator ameliorates diabetes-induced cardiac dysfunction Regul Pept 177 2012 107 115
17. A. Ogasawara, S. Simizu, A. Ito, T. Kawai, Y. Saisho, and I. Takei Inhibition of NO-induced β-cell death by novel NF-κB inhibitor (-)-DHMEQ via activation of Nrf2-ARE pathway Biochem Biophys Res Commun 433 2013 181 187
18. N. Parajuli, T. Ramprasath, V.B. Patel, W. Wang, B. Putko, and J. Mori Targeting angiotensin-converting enzyme 2 as a new therapeutic target for cardiovascular diseases Can J Physiol Pharmacol 92 2014 558 565
19. M. Rosiak, S. Grzeszczak, D.A. Kosior, and M. Postuła Emerging treatments in type 2 diabetes: focus on canagliflozin Ther Clin Risk Manag 10 2014 683 689
20. Z.K. Salman, R. Refaat, E. Selima, A. El Sarha, and M.A. Ismail The combined effect of metformin and l-cysteine on inflammation, oxidative stress and insulin resistance in streptozotocin-induced type 2 diabetes in rats Eur J Pharmacol 714 2013 448 455
21. S.H. Santos, and J.M. Andrade Angiotensin 1-7: a peptide for preventing and treating metabolic syndrome Peptides 59C 2014 34 41
22. S.H. Santos, J.F. Braga, E.G. Mario, L.C. Pôrto, G. Rodrigues-Machado Mda, and A. Murari Improved lipid and glucose metabolism in transgenic rats with increased circulating angiotensin-(1-7) Arterioscler Thromb Vasc Biol 30 2010 953 961
23. S.H. Santos, L.R. Fernandes, E.G. Mario, A.V. Ferreira, L.C. Pôrto, and J.I. Alvarez-Leite Mas deficiency in FVB/N mice produces marked changes in lipid and glycemic metabolism Diabetes 57 2008 340 347
24. S.H. Santos, J.F. Giani, V. Burghi, J.G. Miquet, F. Qadri, and J.F. Braga Oral administration of angiotensin-(1-7) ameliorates type 2 diabetes in rats J Mol Med (Berl) 92 2014 255 265
25. R.A. Santos Angiotensin-(1-7) Hypertension 63 2014 1138 1147
26. R.A. Santos, A.C. Simoes e Silva, C. Maric, D.M. Silva, R.P. Machado, and I. de Buhr Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas Proc Natl Acad Sci U S A 100 2003 8258 8263
27. L. Scarfò, and P. Ghia Reprogramming cell death: BCL2 family inhibition in hematological malignancies Immunol Lett 155 2013 36 39
28. S. Snigdha, E.D. Smith, G.A. Prieto, and C.W. Cotman Caspase-3 activation as a bifurcation point between plasticity and cell death Neurosci Bull 28 2012 14 24
29. J. Tian, L. Zhang, Y. Zhou, J. Xiao, S. Li, and Y. Chen Angiotensin-(1-7) attenuates damage to podocytes induced by preeclamptic serum through MAPK pathways Int J Mol Med 34 2014 1057 1064
30. B.D. Uhal, H. Nguyen, M. Dang, I. Gopallawa, J. Jiang, and V. Dang Abrogation of ER stress-induced apoptosis of alveolar epithelial cells by angiotensin 1-7 Am J Physiol Lung Cell Mol Physiol 305 2013 L33 L41
31. Y. Wang, C. Tikellis, M.C. Thomas, and J. Golledge Angiotensin converting enzyme 2 and atherosclerosis Atherosclerosis 226 2013 3 8
32. Y. Yagishita, T. Fukutomi, A. Sugawara, H. Kawamura, T. Takahashi, and J. Pi Nrf2 protects pancreatic β-cells from oxidative and nitrosative stress in diabetic model mice Diabetes 63 2014 605 618
33. H.Y. Yang, Y.F. Bian, H.P. Zhang, F. Gao, C.S. Xiao, and B. Liang Angiotensin-(1-7) treatment ameliorates angiotensin II-induced apoptosis of human umbilical vein endothelial cells Clin Exp Pharmacol Physiol 39 2012 1004 1010
34. L. Yuan, Y. Li, G. Li, Y. Song, and X. Gong Ang(1-7) treatment attenuates β-cell dysfunction by improving pancreatic microcirculation in a rat model of Type 2 diabetes J Endocrinol Invest 36 2013 931 937
35. K. Zhang, X. Meng, D. Li, J. Yang, J. Kong, and P. Hao Angiotensin(1-7) attenuates the progression of streptozotocin-induced diabetic renal injury better than angiotensin receptor blockade Kidney Int 2014 10.1038/ki.2014.274 [Epub ahead of print]